Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Altimmune Inc (NASDAQ: ALT) closed at $5.70 in the last session, down -1.04% from day before closing price of $5.76. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 2.19 million shares were traded. ALT stock price reached its highest trading level at $5.89 during the session, while it also had its lowest trading level at $5.6.
Ratios:
We take a closer look at ALT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $26.UBS initiated its Buy rating on November 12, 2024, with a $26 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share. On Aug 19 ’24, another insider, Drutz David, who serves as the Director of the company, sold 16,011 shares for $6.90 each. As a result, the insider received 110,547 and left with 41,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 438978048 and an Enterprise Value of 314070752. For the stock, the TTM Price-to-Sale (P/S) ratio is 23359.00 while its Price-to-Book (P/B) ratio in mrq is 3.12. Its current Enterprise Value per Revenue stands at 15703.537 whereas that against EBITDA is -3.204.
Stock Price History:
The Beta on a monthly basis for ALT is 0.60, which has changed by -0.35955054 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $3.55. The 50-Day Moving Average of the stock is 9.90%, while the 200-Day Moving Average is calculated to be -13.79%.
Shares Statistics:
According to the various share statistics, ALT traded on average about 2.65M shares per day over the past 3-months and 2932270 shares per day over the past 10 days. A total of 77.83M shares are outstanding, with a floating share count of 75.98M. Insiders hold about 1.35% of the company’s shares, while institutions hold 53.18% stake in the company. Shares short for ALT as of 1745971200 were 22577420 with a Short Ratio of 8.54, compared to 1743379200 on 21815146. Therefore, it implies a Short% of Shares Outstanding of 22577420 and a Short% of Float of 29.549998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
